| Name | β-Neoendorphin |
|---|---|
| Synonyms |
L-Proline, L-tyrosylglycylglycyl-L-phenylalanyl-L-leucyl-N-(diaminomethylene)-L-ornithyl-L-lysyl-L-tyrosyl-
L-Tyrosylglycylglycyl-L-phenylalanyl-L-leucyl-N-(diaminomethylene)-L-ornithyl-L-lysyl-L-tyrosyl-L-proline β-Neoendorphin β-neo-endorphin b-Neo-Endorphin |
| Description | β-Neo-Endorphin is an endogenous opioid peptide. β-Neo-Endorphin is a hypothalamic “big” Leu-enkephalin of porcine origin. β-Neo-Endorphin shows activation of the Erk1/2, MMP-2 and MMP-9[1][2]. |
|---|---|
| Related Catalog | |
| Target |
ERK1 ERK2 MMP-2 MMP-9 |
| In Vitro | β-Neo-Endorphin (0-20 μM, 20 h) stimulates wound healing in human keratinocytes[2]. β-Neo-Endorphin (promotes wound healing through activation of the Erk1/2 signaling pathway in human keratinocytes[2]. β-Neo-Endorphin (0-20 μM, 12 h) stimulates keratinocyte migration through activation of metalloproteinase (MMP)-2 and -9[2]. β-Neo-Endorphin (12 h) stimulates migration in the fibroblast[2]. Cell Viability Assay[2] Cell Line: Human keratinocytes (HaCaT) Concentration: 0, 5, 10 and 20 μM Incubation Time: 20 h Result: Significantly increased the wound closure. Had no observable effect on cell viability. Western Blot Analysis[2] Cell Line: Human keratinocytes (HaCaT) Concentration: 0, 5, 10 and 20 μM Incubation Time: 12 h Result: Activated Erk1/2, phosphorylated P90RSK and Elk-1, showed significant upregulation of MMP-2 and -9 expression. |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C54H77N13O12 |
| Molecular Weight | 1100.27000 |
| Exact Mass | 1099.58000 |
| PSA | 418.21000 |
| LogP | 1.59 |
| Index of Refraction | 1.653 |